Apple Watch Series 10 won’t include health feature amid patent dispute in the US

Apple Watch Series 10 users in the US will be among those who cannot use one of the device’s features due to a ban imposed.

The company has been required to disable the feature for almost a year due to an ongoing dispute with health technology company Masimo.

The medical device company accused Apple of infringing its pulse oximetry patent and has taken the matter to court. The situation has halted the sales of the Apple Watch Series 9 and Apple Watch Ultra 2 in the US.

At the beginning of this year, the court barred the company from importing the said watches to the US.

Now, Apple’s latest smartwatch series reportedly won’t include a blood oxygen feature in the US either. Users from other countries don’t seem to be affected.

The blood oxygen sensor was first introduced to Apple smartwatches in 2020 with the launch of its Apple Watch Series 6 devices.

Apple presented the Apple Watch 10 series with an upgraded Apple Watch Ultra 2 during this year’s “Glowtime” event on September 9th in Cupertino, California. The launch event also included the new iPhone 16 and AirPods 4.